Brookfield Asset Management
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-21 23:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-11-09 | Read on SEC.gov |
| 8-K | 2026-11-06 | Read on SEC.gov |
| 8-K | 2026-10-13 | Read on SEC.gov |
| 8-K | 2026-10-01 | Read on SEC.gov |
| 8-K | 2026-10-01 | Read on SEC.gov |
| 8-K | 2026-09-28 | Read on SEC.gov |
| 8-K | 2026-09-16 | Read on SEC.gov |
| 8-K | 2026-09-14 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-21 14:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $3.94B | Annual | 2025-12-31 | 2026-03-02 | 10-K |
| Net income | $2.40B | Annual | 2025-12-31 | 2026-03-02 | 10-K |
| Operating cash flow | $2.10B | Annual | 2025-12-31 | 2026-03-02 | 10-K |
| Total assets | $17.05B | As of | 2025-12-31 | 2026-03-02 | 10-K |
| Total liabilities | $6.74B | As of | 2025-12-31 | 2026-03-02 | 10-K |
| Cash and cash equivalents | $1.58B | As of | 2025-12-31 | 2026-03-02 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 8.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Carried interest allocations is the largest reported line at 35.55% of revenue, across 9 reported segments.
- No single line clears half of revenue; Credit is next at 26.15%, spreading the business across more than one real driver.
Revenue annual, last 5 years
Latest year +21.03% YoY
Margins
- Gross margin
- 70.20%
- Operating margin
- 65.84%
- Net margin
- 53.93%
Key ratios & quality
- Enterprise valuei
- 80.24B
- Altman Z-Scorei
- 8.11
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -- | -- | 4.06B | 3.98B | 4.82B |
| Gross profit | -- | -- | 2.67B | 2.84B | 3.24B |
| Selling & admin expenses | -- | -- | 56.00M | 64.00M | 56.00M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | 2.62B | 2.42B | 3.03B |
| Pretax profit | -- | -- | 2.55B | 2.55B | 2.93B |
| Tax | -- | -- | 417.00M | 438.00M | 527.00M |
| Net profit | -- | -- | 2.14B | 2.11B | 2.40B |
| Basic EPS | -- | -- | 1 | 1 | 2 |
| Diluted EPS | -- | -- | 1.16 | 1.35 | 1.54 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 1.09B | 1.25B | 1.39B | 1.34B | 1.75B | 2.15B |
| Gross profit | 749.00M | 761.00M | 905.00M | 887.00M | 795.00M | 1.03B |
| Selling & admin expenses | 18.00M | 23.00M | 9.00M | 22.00M | 25.00M | 75.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 586.00M | 763.00M | 947.00M | 863.00M | 1.21B | 1.40B |
| Pretax profit | 659.00M | 770.00M | 914.00M | 696.00M | 1.33B | 3.33B |
| Tax | 75.00M | 78.00M | 299.00M | 110.00M | 162.00M | 331.00M |
| Net profit | 584.00M | 692.00M | 615.00M | 586.00M | 1.17B | 3.00B |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 2 |
| Diluted EPS | 0.38 | 0.45 | 0.34 | 0.38 | 0.56 | 1.65 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | -- | 783.00M | 895.00M | 4.93B | 6.93B |
| Cash & ST investments | -- | 1.00M | 9.00M | 404.00M | 1.58B |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | -- | 3.16B | 3.21B | 14.16B | 17.05B |
| Total current liabilities | -- | 784.00M | 1.12B | 1.54B | 2.01B |
| Short-term debt | -- | -- | 256.00M | 251.00M | 462.00M |
| Long-term debt | -- | -- | -- | 897.00M | 3.16B |
| Total liabilities | -- | 784,000,000.00 | 1,120,000,000.00 | 2,966,000,000.00 | 6,737,000,000.00 |
| Total equity | -- | 2.38B | 2.09B | 11.19B | 10.31B |
| Retained earnings | -- | 19.00M | -35.00M | -488.00M | -851.00M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 5.96B | 6.52B | 6.93B | 6.40B | 7.52B | 9.69B |
| Cash & ST investments | 480.00M | 1.06B | 1.58B | 1.10B | 1.50B | 688.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 16.14B | 16.52B | 17.05B | 17.94B | 20.08B | 27.41B |
| Total current liabilities | 2.93B | 2.98B | 2.01B | 2.20B | 2.84B | 6.08B |
| Short-term debt | 507.00M | 453.00M | 462.00M | -- | 589.00M | 1.68B |
| Long-term debt | 1.67B | 2.35B | 3.16B | 3.83B | 4.67B | 5.01B |
| Total liabilities | 5,113,000,000.00 | 5,847,000,000.00 | 6,737,000,000.00 | 6,702,000,000.00 | 8,212,000,000.00 | 12,680,000,000.00 |
| Total equity | 11.03B | 10.67B | 10.31B | 11.24B | 11.87B | 14.73B |
| Retained earnings | -715.00M | -704.00M | -851.00M | -1.05B | -950.00M | 884.00M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -- | -374.00M | 1.44B | 1.61B | 2.10B |
| Depreciation & amortization | -- | 13.00M | 14.00M | 14.00M | 40.00M |
| Free cash flow | -- | -387.00M | 1.44B | 1.61B | 2.10B |
| Dividends paid | -- | -3.18B | -2.10B | -2.48B | -2.82B |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -412.00M |
| Ending cash balance | -- | 3.55B | 2.67B | 404.00M | 1.58B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 529.00M | 745.00M | 706.00M | 339.00M | 545.00M | 554.00M |
| Depreciation & amortization | 11.00M | 16.00M | 10.00M | 13.00M | 13.00M | 60.00M |
| Free cash flow | 529.00M | 745.00M | 706.00M | 339.00M | 545.00M | 554.00M |
| Dividends paid | -702.00M | -706.00M | -703.00M | -809.00M | -802.00M | -802.00M |
| Stock buybacks / issuance | 0 | -69.00M | -418.00M | -376.00M | -200.00M | 407.00M |
| Ending cash balance | 480.00M | 1.06B | 1.58B | 1.10B | 1.50B | 688.00M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | 0.80 | 20.17 | 20.33 | 43.73 |
| ROA %i | -- | 0.60 | 14.11 | 14.25 | 23.19 |
| ROIC %i | -- | 0.89 | 20.20 | 23.35 | 29.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | 136.29 | 140.46 | 69.34 |
| FCF / sales %i | -- | -- | 132.64 | 130.08 | 45.59 |
| Current ratioi | -- | 1.00 | 0.80 | 3.20 | 3.45 |
| Quick ratioi | -- | 1.00 | 0.80 | 3.09 | 3.38 |
| Debt / assetsi | -- | -- | 7.99 | 8.11 | 21.25 |
| LT debt / equityi | -- | -- | -- | 10.25 | 38.93 |
| Interest coveragei | -- | 7.33 | 7.35 | 4.98 | 11.83 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 13.78 | 16.89 | 43.73 | 31.35 | 35.10 | 52.84 |
| ROA %i | 7.93 | 9.46 | 23.19 | 15.32 | 15.49 | 21.52 |
| ROIC %i | 12.73 | 13.79 | 29.39 | 28.02 | 26.96 | 37.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 116.17 | 117.20 | 69.34 | 71.43 | 85.95 | 131.44 |
| FCF / sales %i | 43.23 | 59.80 | 45.59 | 48.75 | 48.59 | 41.03 |
| Current ratioi | 2.04 | 2.19 | 3.45 | 2.91 | 2.64 | 1.59 |
| Quick ratioi | 2.04 | 2.19 | 3.38 | 2.91 | 2.64 | 1.59 |
| Debt / assetsi | 13.49 | 16.97 | 21.25 | 21.33 | 26.21 | 25.32 |
| LT debt / equityi | 19.72 | 27.77 | 38.93 | 50.40 | 62.20 | 55.86 |
| Interest coveragei | 3.32 | 4.20 | 11.83 | 9.24 | 9.70 | 11.62 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Brookfield Asset Management discussion 0 comments